CROHN’S DISEASE REAL WORLD THERAPY IN PREVALENT CD-PATIENTS IN GERMANY - THERE IS STILL A GREAT BURDEN OF DISEASE
Beatriz Antolin-Fontes 1
Evi Zhuleku 2
Andras Borsi 3
Riikka Nissinen 4
Ivana Bravatà 5
Jennifer Norma Barthelmes 6
Manuela Le Bars 7
Jennifer Lee
Bernd Bokemeyer 8
Thomas Wilke 9
Marco Ghiani 10
1 Ingress-Health HWM GmbH, Berlin, Germany
2 Ingress Health HWM GmbH, Berlin, Germany
3 Janssen-Cilag Ltd, High Wycombe, United Kingdom
4 Janssen-Cilag Oy, Espoo, Finland
5 Janssen-Cilag S.p.A., Milan, Italy
6 Janssen-Cilag GmbH, Neuss, Germany
7 Janssen-Cilag SARL, Issy-les-Moulineaux, France
8 Gastroenterology Practice Minden, Minden, Germany
9 Institut Für Pharmakoökonomie Und Arzneimittellogistik Wismar E.V., Wismar, Germany
10 Institut für Pharmakoökonomie und Arzneimittellogistik ev., Wismar, Germany
Session
IBD: Cross-sectional
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]